RecruitingNCT06666530

Quality of Life Related to the Care of Women Living With HIV During the Perinatal Period


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

100 participants

Start Date

Jun 19, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

"The improvement of patient care by assessing the Quality of Life Related to Care (QLRC) in pregnant women living with HIV is of great importance for informing decision-making, resource allocation, and health policy formulation Prospective descriptive survey of women living with HIV followed for a pregnancy in the Infectious diseases department of Bichat-Claude Bernard Hospital, PARIS, France, between the first obstetric ultrasound and the 28th week of amenorrhea. After recruitment during a follow-up consultation: Information regarding the prenatal and perinatal management of HIV and the infant's outcomes up to 12 months will be collected retrospectively through the medical records. Three self-questionnaires, either completed independently or with assistance, will be administered at inclusion (between the first obstetric ultrasound and 28 weeks of amenorrhea), during the third trimester of pregnancy, and at 1 year postpartum."


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is looking at the quality of life and care experiences of pregnant women living with HIV during their prenatal period and after birth. The goal is to better understand what these women go through so that healthcare providers can offer better, more supportive care during and after pregnancy. **You may be eligible if...** - You are a woman living with HIV - You are 18 years old or older - You are pregnant and your due date is between your first ultrasound and 28 weeks of pregnancy - You have been informed about the study **You may NOT be eligible if...** - You decline to participate in the study - You do not speak French Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionary

Three self-questionnaires, either completed independently or with assistance, will be administered at inclusion (between the first obstetric ultrasound and 28 weeks of amenorrhea), during the third trimester of pregnancy, and at 1 year postpartum


Locations(1)

Hôpital Bichat-Claude Bernard

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06666530


Related Trials